Saurashtra News

Creative Biolabs’ Solutions to Drive Vaccine Discovery

 Breaking News
  • No posts were found

Creative Biolabs’ Solutions to Drive Vaccine Discovery

March 24
17:20 2022
Creative Biolabs is fully capable of providing first-class vaccine design services to help generate highly immunogenic and safe vaccine candidates efficiently and cost-effectively, thanks to cutting-edge biotech technologies.

New York, USA – March 21, 2022 – The breakout of COVID-19, as well as other severe diseases like Zika, has prompted experts from all over the world to work tirelessly to develop efficient vaccines against a variety of pathogens. For over a decade, Creative Biolabs has been exploring vaccine fields and has supported hundreds of successful projects of vaccine discovery with its high-end technologies and qualified products. Creative Biolabs’ scientists are confident in their ability to assist in the design and development of an efficient vaccine that can turn the tide.

Creative Biolabs’ solution center offers vaccine design services, covering the mainstream vaccine types on the market and also those under preclinical studies. Requests for new vaccine type discovery can also be handled by experienced scientists, who will provide a detailed and tailored proposal after in-depth discussion and a target is fixed.

Representatives

A subunit vaccine only contains the required antigen instead of all the molecules that make up the microbe, minimizing the risk of adverse reaction, which is widely applied in both preclinical studies and clinic usages (especially for those patients with a weak immune system). Creative Biolabs has not only the antigen products suitable for the discovery of a subunit vaccine, but also masters recombinant DNA technology to artificially produce antigen molecules from microbes.

The design of RNA and DNA vaccines is another tactic of Creative Biolabs that has expertise in gene engineering and can solve the general problems faced by DNA and RNA vaccines and thereby improve their efficacy.

* Optimize antigens into better immunogens.

* Utilize exogenous cytokines.

* Adopt potent adjuvants such as bacterial DNA sequences.

In addition to the vaccine design process and antigen products that matter, adjuvants are also core factors that shape the potency and the ability to elicit an immune response of a vaccine candidate.

* Aluminum

* Oil Adjuvant

* Saponin

* Lipopolysaccharide

* CpG

* PRRs Agonist

Creative Biolabs has developed a systematic vaccine development workflow and has a substantial inventory of compounds available for supply on a global scale. For additional information, go to https://www.creative-biolabs.com/vaccine.

About

On a global scale, Creative Biolabs is a biotechnology expert, delivering professional solutions and high-quality products to pharmaceutical firms, research institutes, and universities. The scientists have over ten years of experience in vaccine research and development. Creative Biolabs has made a significant contribution to the COVID-19 situation by providing technical support and research-use products.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/vaccine